TuHURA Biosciences, Inc. HURA Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s additional paid-in capital?
- TuHURA Biosciences, Inc. (HURA) reported additional paid-in capital of $171.57M in Q1 2026.
- How has TuHURA Biosciences, Inc.'s additional paid-in capital changed year-over-year?
- TuHURA Biosciences, Inc.'s additional paid-in capital increased by 31.6% year-over-year, from $130.38M to $171.57M.
- What is the long-term trend for TuHURA Biosciences, Inc.'s additional paid-in capital?
- Over 3 years (2022 to 2025), TuHURA Biosciences, Inc.'s additional paid-in capital has grown at a 4.8% compound annual growth rate (CAGR), from $140.57M to $161.78M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.